[The value of lysinopril in cardiac insufficiency]
- PMID: 2176346
[The value of lysinopril in cardiac insufficiency]
Abstract
Owing to its original pharmacokinetic profile, lisinopril can be taken once a day, independently of meals, providing a 24-hour inhibition of the angiotensin-converting enzyme. Lisinopril is a potent angiotensin-converting enzyme inhibitor. Administered in doses of 2.5 to 20 mg per day, it improves the functional and haemodynamic state of patients whose congestive heart failure is refractory to the digitalis-diuretic treatment. The drug is well tolerated, and no severe side-effects have been reported. Lisinopril seems to be at least as effective as captopril in congestive heart failure, and it has over the latter the advantage of a once a day dosage therapy.
Similar articles
-
Lisinopril in the treatment of congestive heart failure.J Hum Hypertens. 1989 Jun;3 Suppl 1:83-7. J Hum Hypertens. 1989. PMID: 2550647 Review.
-
Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.Z Kardiol. 1991;80 Suppl 2:35-9. Z Kardiol. 1991. PMID: 1850941 Review.
-
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
-
[Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].Z Kardiol. 1991;80 Suppl 2:40-3. Z Kardiol. 1991. PMID: 1850942 Clinical Trial. German.
-
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors].Verh Dtsch Ges Inn Med. 1991;97:545-8. Verh Dtsch Ges Inn Med. 1991. PMID: 1667051 Clinical Trial. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical